0001181431-14-028427.txt : 20140806
0001181431-14-028427.hdr.sgml : 20140806
20140806162617
ACCESSION NUMBER: 0001181431-14-028427
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140806
FILED AS OF DATE: 20140806
DATE AS OF CHANGE: 20140806
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Loxo Oncology, Inc.
CENTRAL INDEX KEY: 0001581720
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462996673
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 LANDMARK SQUARE, SUITE 1122
CITY: STAMFORD
STATE: CT
ZIP: 06901
BUSINESS PHONE: 203-658-4749
MAIL ADDRESS:
STREET 1: 1 LANDMARK SQUARE, SUITE 1122
CITY: STAMFORD
STATE: CT
ZIP: 06901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DRANT RYAN D
CENTRAL INDEX KEY: 0001302106
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36562
FILM NUMBER: 141020293
MAIL ADDRESS:
STREET 1: 1119 ST PAUL STREET
CITY: BALTIMORE
STATE: MD
ZIP: 21202
4
1
rrd413986.xml
X0306
4
2014-08-06
0
0001581720
Loxo Oncology, Inc.
LOXO
0001302106
DRANT RYAN D
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM
MD
21093
0
0
1
0
Common Stock
2014-08-06
4
C
0
1558651
A
1558651
I
See Note 2
Common Stock
2014-08-06
4
P
0
230769
13
A
1789420
I
See Note 2
Series B Convertible Preferred Stock
2014-08-06
4
C
0
1558651
D
Common Stock
1558651
0
I
See Note 2
In connection with the consummation of the Issuer's initial public offering on August 6, 2014, each share of Series B Convertible Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration. The Series B Convertible Preferred Stock had no expiration date.
The Reporting Person is a director of NEA 14 GP, LTD, which is the sole general partner of NEA Partners 14, L.P. ("NEA Partners 14"). NEA Partners 14 is the sole general partner of New Enterprise Associates 14, L.P. ("NEA 14"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 14 shares in which the Reporting Person has no pecuniary interest.
NEA 14 purchased these shares directly from the Issuer in a private placement.
/s/ Sasha Keough, attorney-in-fact
2014-08-06